AGITG - Australasian Gastro Intestinal Trial Group

Personalised bowel cancer treatments

Personalising cancer treatment for individuals is proving to be effective. Medical oncologist Professor Tim Price claims that by assessing the gene profile of a patient, doctors can determine which treatments will work the best.

Bowel cancer patient Joshua Cilento who was on a cancer trial funded by the Australasian Gastro-Intestinal Trials Group. Watch his story below.

Share